1. Home
  2. CPSH vs XGN Comparison

CPSH vs XGN Comparison

Compare CPSH & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CPS Technologies Corp.

CPSH

CPS Technologies Corp.

HOLD

Current Price

$5.33

Market Cap

68.9M

ML Signal

HOLD

Logo Exagen Inc.

XGN

Exagen Inc.

HOLD

Current Price

$2.70

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPSH
XGN
Founded
1984
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Building Materials
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.9M
64.5M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
CPSH
XGN
Price
$5.33
$2.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$6.00
$8.86
AVG Volume (30 Days)
237.4K
177.8K
Earning Date
04-28-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
113.64
N/A
EPS
0.03
N/A
Revenue
N/A
N/A
Revenue This Year
$16.41
$8.12
Revenue Next Year
$20.16
$13.00
P/E Ratio
$169.63
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$2.59
52 Week High
$6.85
$12.23

Technical Indicators

Market Signals
Indicator
CPSH
XGN
Relative Strength Index (RSI) 64.46 34.43
Support Level $5.02 $2.59
Resistance Level $6.85 $3.29
Average True Range (ATR) 0.39 0.17
MACD 0.05 -0.01
Stochastic Oscillator 77.78 12.05

Price Performance

Historical Comparison
CPSH
XGN

About CPSH CPS Technologies Corp.

CPS Technologies Corp designs, manufactures, and sells high-performance material solutions for customers across various markets, including transportation, energy, automotive, electronics, telecommunications, aerospace, and defense. The company develops and applies proprietary expertise in metal matrix composites (MMCs), which are engineered materials combining metals and ceramics to achieve enhanced performance properties. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers. The majority of the company's revenue is derived from the sale of its products in the United States of America.

About XGN Exagen Inc.

Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.

Share on Social Networks: